HS220

CAS No. 1570374-32-1

HS220( —— )

Catalog No. M28488 CAS No. 1570374-32-1

HS220 is an inhibitor of TAK1 which plays a key role in the signaling pathways of inflammation and cell survival.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 282 Get Quote
10MG 462 Get Quote
25MG 737 Get Quote
50MG 981 Get Quote
100MG 1341 Get Quote
500MG 2691 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    HS220
  • Note
    Research use only, not for human use.
  • Brief Description
    HS220 is an inhibitor of TAK1 which plays a key role in the signaling pathways of inflammation and cell survival.
  • Description
    HS220 is an inhibitor of TAK1 which plays a key role in the signaling pathways of inflammation and cell survival.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    MAPK/ERK Signaling
  • Target
    p38 MAPK
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1570374-32-1
  • Formula Weight
    323.35
  • Molecular Formula
    C18H17N3O3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 83.33 mg/mL (257.71 mM)
  • SMILES
    O=C(O)C1=CC=CC(=C1)C(=O)NC2=NC=3C=CC=CC3N2CCC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • 16,17-Epoxypregnenol

    16,17-Epoxypregnenol

  • PAF (C16)

    PAF (C16) is a potent MAPK and MEK/ERK activator that induces increased vascular permeability. PAF (C16) (PAF (C16)) is a platelet-activating factor, a phospholipid-derived mediator and a ligand for PAF G protein-coupled receptor (PAFR). PAF (C16) has shown anti-apoptotic and anti-inflammatory activity in vitro, inhibiting Caspase-dependent apoptosis by interacting with its receptor (PAF-R) to perform cell signaling.

  • MW181 hydrochloride

    MW181 (MW01-10-181SRM) is an isoform-selective, brain-permeable, and orally bioavailable small molecule inhibitor of p38α MAPK with Ki of 184 nM.